Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OXYMORPHONE vs PALIVIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OXYMORPHONE vs PALIVIZUMAB: Safety Overview

Metric OXYMORPHONE PALIVIZUMAB
Total FAERS Reports 38,077 11,419
Deaths Reported 22,403 1,248
Death Rate 58.8% 10.9%
Hospitalizations 2,692 6,461
Average Patient Age 40.2 yrs 0.8 yrs
% Female Patients 46.0% 42.2%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Hikma Pharmaceuticals USA Inc. Swedish Orphan Biovitrum AB (publ)
Route ORAL INTRAMUSCULAR
Marketing Status Discontinued Prescription